markedly significantp ≤ 0.05
Co-treatment with BM-MSCs and beetroot created markedly significant ( p ≤ 0.05) decrease (127.8 ± 22.78 pg/mL) over the Cis group ( Figure 5 ). 3.2.4.
Co-treatment with BM-MSCs and beetroot created markedly significant ( p ≤ 0.05) decrease (127.8 ± 22.78 pg/mL) over the Cis group ( Figure 5 ). 3.2.4.